Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 10,000 shares at $75.61 ($756K) on 2016-12-19, disclosed to the SEC on 2017-01-04.
Open-market sale of $756k EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.61 | 2,683 | $203K | 26.8% |
| 2 | $75.61 | 7,317 | $553K | 73.2% |
| Total | $75.61 avg | 10,000 | $756K | 100% |
| Filing → |
| EGRX | SELL | 2017-03-24 | $569K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $203K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $7.0M | — | Filing → |